Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Annals of the Rheumatic Diseases
|
April 4, 2020
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
Carina Mihai, Rucsandra Dobrota, Maria Schröder, et al.
Arthritis Research & Therapy
|
May 20, 2023
Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis
Gabriella Nagy, Rucsandra Dobrota, Mike Oliver Becker, et al.
The Journal of Rheumatology
|
March 17, 2020
The Challenge of Very Early Systemic Sclerosis: A Combination of Mild and Early Disease?
Elisabeth Blaja, Suzana Jordan, Carmen-Marina Mihai, et al.
Rheumatology (Oxford, England)
|
November 8, 2022
Vision transformer assisting rheumatologists in screening for capillaroscopy changes in systemic sclerosis: an artificial intelligence model
Alexandru Garaiman, Farhad Nooralahzadeh, Carina Mihai, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie
|
June 4, 2015
[The Current State of Intercultural Opening in Psychosocial Services--The Results of an Assessment in an Inner-City District of Berlin]
Simone Penka, Hanna Faißt, Azra Vardar, et al.
Arthritis Research & Therapy
|
March 12, 2014
Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients
Jeannine Günther, Angela Kill, Mike Oliver Becker, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
June 2, 2020
Serum cytokines and their predictive value in pulmonary involvement of systemic sclerosis
Mike Oliver Becker, Mislav Radic, Katrin Schmidt, et al.
Journal of Scleroderma and Related Disorders
|
August 1, 2025
The serum levels of specific autoantibodies in systemic sclerosis predict a more severe skin involvement
Hannah Dengler, Maya Vonow-Eisenring, Mike Oliver Becker, et al.
Annals of the Rheumatic Diseases
|
June 8, 2018
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model
Wanlong Wu, Suzana Jordan, Mike Oliver Becker, et al.
RMD Open
|
July 25, 2024
Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?
Lea Stamm, Alexandru Garaiman, Mike Oliver Becker, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Annals of the Rheumatic Diseases
|
April 4, 2020
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
Carina Mihai, Rucsandra Dobrota, Maria Schröder, et al.
Arthritis Research & Therapy
|
May 20, 2023
Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis
Gabriella Nagy, Rucsandra Dobrota, Mike Oliver Becker, et al.
The Journal of Rheumatology
|
March 17, 2020
The Challenge of Very Early Systemic Sclerosis: A Combination of Mild and Early Disease?
Elisabeth Blaja, Suzana Jordan, Carmen-Marina Mihai, et al.
Rheumatology (Oxford, England)
|
November 8, 2022
Vision transformer assisting rheumatologists in screening for capillaroscopy changes in systemic sclerosis: an artificial intelligence model
Alexandru Garaiman, Farhad Nooralahzadeh, Carina Mihai, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie
|
June 4, 2015
[The Current State of Intercultural Opening in Psychosocial Services--The Results of an Assessment in an Inner-City District of Berlin]
Simone Penka, Hanna Faißt, Azra Vardar, et al.
Arthritis Research & Therapy
|
March 12, 2014
Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients
Jeannine Günther, Angela Kill, Mike Oliver Becker, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
June 2, 2020
Serum cytokines and their predictive value in pulmonary involvement of systemic sclerosis
Mike Oliver Becker, Mislav Radic, Katrin Schmidt, et al.
Journal of Scleroderma and Related Disorders
|
August 1, 2025
The serum levels of specific autoantibodies in systemic sclerosis predict a more severe skin involvement
Hannah Dengler, Maya Vonow-Eisenring, Mike Oliver Becker, et al.
Annals of the Rheumatic Diseases
|
June 8, 2018
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model
Wanlong Wu, Suzana Jordan, Mike Oliver Becker, et al.
RMD Open
|
July 25, 2024
Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?
Lea Stamm, Alexandru Garaiman, Mike Oliver Becker, et al.
Page
of 6